Adacyte Therapeutics is a multinational company, founded in 2018, committed to the development and commercialization of innovative and holistic therapeutic solutions.
About Us
Adacyte Therapeutics
Adacyte Therapeutics is a multinational company committed to the development of unique health technologies aimed at improving patients health and its quality of life.
“We are guided by our patients and their needs”
Adacyte Therapeutics was born out of a profound desire and responsibility to provide proven therapeutic alternatives for patients suffering from complex diseases.
We offer Granulocyte-Monocyte Apheresis (GMA) with Adacolumn®, a non pharmacological treatment for autoimmune diseases such as: Inflammatory Bowel Disease, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Ocular Behçet’s Disease or Pustular Psoriasis, which is both effective and avoid the extremely undesirable side effects of existing drug therapies.
“We are passionate about Apheresis”
As no two patients are exactly the same, Adacolumn® provides a unique non-pharmacological and non-surgical approach to improve patient’s outcomes which takes into account the diversity of their needs.
“A patient-friendly revolution in the treatment of autoimmune inflammatory diseases”
OUR QUALITY POLICY
The company operates under a quality management system according to the standards ISO 9001 and ISO 13485 (see enclosed ISO 9001 third party certificate).
Contact UsFor more information
Get in touch